Endothelin and isoproterenol counter-regulate cAMP and mitogen-activated protein kinases

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Wu Wong, Jinshyun R ^a   Opgenorth, Terry J ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

cAMP; Endothelin; Isoproterenol; MAP kinase; Smooth muscle cells

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIN 1; ISOPRENALINE; PROTEIN KINASE (CALCIUM,CALMODULIN);

ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; DRUG INTERACTION; ENZYME ACTIVATION; HUMAN; ION EXCHANGE CHROMATOGRAPHY; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADRENERGIC BETA-AGONISTS; BLOTTING, WESTERN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; CHROMATOGRAPHY, ION EXCHANGE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG INTERACTIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIN-1; ENZYME ACTIVATION; HUMANS; ISOPROTERENOL;

EID: 0031630238     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00053     Document Type: Article

References (30)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863-7.
3. Sokolovsky M. Structure-function relationships of endothelins, sarafotoxins, and their receptor subtypes. J Neurochem 1992;59: 809-21.
4. Kozuka M, Ito T, Hirose S, et al. Purification and characterization of bovine lung endothelin receptor. J Biol Chem 1991;266: 16892-6.
5. Wada K, Tabuchi H, Ohba R, et al. Purification of an endothelin receptor from human placenta. Biochem Biophys Res Commun 1990;167:251-7.
6. Arai H, Hori S, Arimori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-2.
7. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature 1990;348:732-5.
8. A-selective receptor antagonist. J Pharmacol Exp Ther 1996;276:473-81.
9. A receptor antagonist. J Pharmacol Exp Ther 1993;264:1040-6.
10. Sugden PH, Bogoyevitch MA. Endothelin-1-dependent signaling pathways in the myocardium. Trends Cardiovasc Med 1996;6:87-94.
11. Wu-Wong JR, Chiou WJ, Huang ZJ, Vidal MJ, Opgenorth TJ. Endothelin receptor in human smooth muscle cells: antagonist potency differs on agonist-evoked responses. Am J Physiol 1994;267:C1185-95.
12. +2-dependent pathway. Am J Physiol 1996;271:C869-77.
13. Enoki T, Miwa S, Sakamoto A, et al. Long-lasting activation of cation current by low concentration of endothelin-1 in mouse fibroblasts and smooth muscle cells of rabbit aorta. Br J Pharmacol 1995;115:479-85.
14. Beall AC, Kato K, Goldenring JR, Rasmussen H, Brophy CM. Cyclin nucleotide-dependent vasorelaxation is associated with the phosphorylation of a small heat shock-related protein. J Biol Chem 1997;272:11283-7.
15. Levin ER. Endothelins. N Engl J Med 1995;333:356-63.
16. Inagami T, Naruse M, Hoover R. Endothelium as an endocrine organ. Annu Rev Physiol 1995;57:171-89.
17. Ehrenreich H, Schilling L. New developments in the understanding of cerebral vasoregulation and vasospasm: the endothelin-nitric oxide network. Cleveland Clin J Med 1995;62:105-16.
18. Lin CW, Miller TR, Witte DG, et al. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells. Mol Pharmacol 1995;47:131-9.
19. Burgering BMT, Bos JL. Regulation of Ras-mediated signalling: more than one way to skin a cat. Trends Biochem Sci 1995;20:18-22.
20. Cobb MH, Boulton TF, Robbins DT. Extracellular signal-regulated kinases: ERKs in progress. Cell Regul 1991;2:965-78.
21. Sokolovsky M. Endothelin receptor heterogeneity, G-proteins, and signaling via cAMP and cGMP cascades. Cell Mol Neurobiol 1995;15:561-71.
22. Crespo P, Cachero TG, Xu N, Gutkind JS. Dual effect of β-adrenergic receptors on mitogen-activated protein kinase. J Biol Chem 1995;270:25259-65.
23. Ladoux A, Frelin C. Endothelins inhibit adenylate cyclase in brain capillary endothelial cells. Biochem Biophys Res Commun 1991; 180:169-73.
24. Simonson MS, Dunn MJ. Endothelin-1 stimulates contract of rat glomerular cells and potentiates β-adrenergic-mediated cyclic adenosine monophosphate accumulation. J Clin Invest 1990;85: 790-7.
25. Sugawara F, Ninomiya H, Okamoto Y, et al. Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelin-A: the role of a wortmannin-sensitive signaling pathway. Mol Pharmacol 1996;49:447-57.
26. Kasuya Y, Abe Y, Hama H, et al. Endothelin-1 activates mitogen-activated protein kinases through two independent signalling pathways in rat astrocytes. Biochem Biophys Res Commun 1994;204: 1325-33.
27. Crews CM, Alessandrini A, Erickson RL. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 1992;258:478-80.
28. Kyriakis JM, App H, Zhang XF, et al. Raf-1 activates MAP kinase-kinase. Nature 1992;358:417-21.
29. Lange-Carter CA, Pleimann CM, Gardner AM, Blumer KJ, Johnson GL. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 1993;260: 315-9.
30. Van Renterghem B, Browning MD, Maller JL. Regulation of mitogen-activated protein kinase activation by protein kinases A and C in a cell-free system. J Biol Chem 1994;269:24666-72.